Dhampur Bio Organics (DBOL) | Financial Analysis & Statements
Dhampur Bio Organics Ltd. Small-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
5.3B
Gross Profit
801.5M
15.25%
Operating Income
-129.0M
-2.45%
Net Income
-220.0M
-4.19%
EPS (Diluted)
₹-3.31
Balance Sheet Metrics
Total Assets
16.4B
Total Liabilities
6.8B
Shareholders Equity
9.6B
Debt to Equity
0.71
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dhampur Bio Organics Income Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 18.4B | 18.4B | 23.7B | 15.3B |
| Cost of Goods Sold | 14.9B | 14.7B | 19.2B | 11.9B |
| Gross Profit | 3.6B | 3.6B | 4.5B | 3.4B |
| Gross Margin % | 19.3% | 19.8% | 19.1% | 22.1% |
| Operating Expenses | ||||
| Research & Development | - | - | - | - |
| Selling, General & Administrative | 439.0M | 642.4M | 944.6M | 499.8M |
| Other Operating Expenses | 910.1M | 820.0M | 739.0M | 630.0M |
| Total Operating Expenses | 1.3B | 1.5B | 1.7B | 1.1B |
| Operating Income | 820.3M | 924.4M | 1.7B | 1.6B |
| Operating Margin % | 4.5% | 5.0% | 7.3% | 10.2% |
| Non-Operating Items | ||||
| Interest Income | 15.9M | 23.1M | 4.8M | 5.2M |
| Interest Expense | 645.5M | 433.6M | 380.8M | 294.2M |
| Other Non-Operating Income | - | - | - | - |
| Pre-tax Income | 157.1M | 654.9M | 1.3B | 1.3B |
| Income Tax | 10.2M | 190.0M | 236.7M | 270.8M |
| Effective Tax Rate % | 6.5% | 29.0% | 17.6% | 20.9% |
| Net Income | 146.9M | 464.9M | 1.1B | 1.0B |
| Net Margin % | 0.8% | 2.5% | 4.7% | 6.7% |
| Key Metrics | ||||
| EBITDA | 1.4B | 1.4B | 2.1B | 1.9B |
| EPS (Basic) | ₹2.21 | ₹7.00 | ₹16.74 | ₹15.41 |
| EPS (Diluted) | ₹2.21 | ₹7.00 | ₹16.74 | ₹15.41 |
| Basic Shares Outstanding | 66387590 | 66387590 | 66387590 | 66387590 |
| Diluted Shares Outstanding | 66387590 | 66387590 | 66387590 | 66387590 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Dhampur Bio Organics Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 88.8M | 59.9M | 1.0B | 229.8M | 138.7M |
| Short-term Investments | 236.8M | 234.0M | 970.0M | - | - |
| Accounts Receivable | 548.0M | 875.3M | 1.5B | 1.1B | 1.1B |
| Inventory | 10.9B | 10.8B | 8.2B | 10.6B | 7.2B |
| Other Current Assets | 70.1M | 91.0M | 69.3M | 30.4M | 477.6M |
| Total Current Assets | 12.3B | 12.5B | 11.2B | 12.2B | 9.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 120.4M | 92.0M | 96.7M | 82.2M | 75.9M |
| Goodwill | 1.6M | 0 | 0 | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.1M | 5.8M | 5.5M | 5.1M | 4.6M |
| Total Non-Current Assets | 11.7B | 10.6B | 9.5B | 7.8B | 6.5B |
| Total Assets | 24.0B | 23.1B | 20.8B | 20.0B | 15.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.2B | 1.4B | 1.6B | 1.7B | 3.0B |
| Short-term Debt | 9.2B | 8.7B | 6.4B | 7.2B | 3.0B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 168.6M | 4.4M | -10.2M | 22.8M | 31.2M |
| Total Current Liabilities | 10.8B | 10.5B | 8.6B | 9.6B | 6.2B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.4B | 1.8B | 1.7B | 1.1B | 1.0B |
| Deferred Tax Liabilities | 396.7M | 425.0M | 349.0M | 339.9M | 307.3M |
| Other Non-Current Liabilities | -6.2M | 600.0K | 600.0K | 12.6M | 54.5M |
| Total Non-Current Liabilities | 3.0B | 2.5B | 2.3B | 1.7B | 1.6B |
| Total Liabilities | 13.9B | 13.0B | 10.9B | 11.2B | 7.8B |
| Equity | |||||
| Common Stock | 663.9M | 663.9M | 663.9M | 663.9M | 663.9M |
| Retained Earnings | 2.3B | 2.4B | 2.1B | 1.0B | -100.0K |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 10.1B | 10.1B | 9.9B | 8.8B | 7.7B |
| Key Metrics | |||||
| Total Debt | 11.6B | 10.6B | 8.1B | 8.3B | 4.0B |
| Working Capital | 1.5B | 2.0B | 2.7B | 2.7B | 2.8B |
Balance Sheet Composition
Dhampur Bio Organics Cash Flow Statement From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | 174.7M | 654.9M | 1.3B | 1.3B |
| Depreciation & Amortization | - | - | - | - |
| Stock-Based Compensation | - | - | - | - |
| Working Capital Changes | 260.3M | -2.0B | 1.8B | -2.9B |
| Operating Cash Flow | 1.1B | -911.3M | 3.5B | -1.2B |
| Investing Activities | ||||
| Capital Expenditures | -1.4B | -1.4B | -2.1B | -1.4B |
| Acquisitions | -100.0K | - | -166.6M | 0 |
| Investment Purchases | - | -240.7M | -16.3M | -12.2M |
| Investment Sales | - | - | 0 | 1.8M |
| Investing Cash Flow | -1.4B | -1.7B | -2.3B | -1.4B |
| Financing Activities | ||||
| Share Repurchases | - | - | - | - |
| Dividends Paid | -167.2M | -231.2M | - | - |
| Debt Issuance | 1.3B | 723.3M | 1.4B | 842.5M |
| Debt Repayment | -642.6M | -783.0M | -634.4M | -507.2M |
| Financing Cash Flow | 887.8M | 2.2B | -278.9M | 4.3B |
| Free Cash Flow | -161.7M | -2.7B | 1.4B | -3.9B |
| Net Change in Cash | 531.5M | -399.3M | 953.5M | 1.6B |
Cash Flow Trend
Dhampur Bio Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
33.58
Price to Book
0.82
Price to Sales
0.39
PEG Ratio
-0.10
Profitability Ratios
Profit Margin
1.17%
Operating Margin
5.62%
Return on Equity
1.45%
Return on Assets
0.61%
Financial Health
Current Ratio
1.13
Debt to Equity
58.45
Beta
0.62
Per Share Data
EPS (TTM)
₹3.56
Book Value per Share
₹144.93
Revenue per Share
₹307.08
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DBOL | 7.9B | 33.58 | 0.82 | 1.45% | 1.17% | 58.45 |
| Venky's (India | 21.4B | 41.84 | 1.48 | 7.90% | 1.48% | 13.06 |
| Apex Frozen Foods | 15.1B | 45.02 | 2.92 | 0.78% | 3.45% | 7.97 |
| Andrew Yule | 11.2B | 108.71 | 3.10 | -0.84% | 3.56% | 33.31 |
| Sharat Industries | 5.8B | 47.12 | 3.84 | 7.28% | 3.27% | 81.98 |
| Mishtann Foods | 5.1B | 1.49 | 0.43 | 34.69% | 23.72% | 3.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.




